Off-Label Litigation: Amarin Sues FDA In Bid To Promote Vascepa Fish Oil

First Amendment lawsuit is most recent challenge of agency’s promotional policies.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America